Truveta is a growing collective of health systems that provide more than 18% of all daily clinical care in the US.
CDC awards Truveta a real-world data contract to study COVID, maternal health, and pediatric care
January 22, 2024 09:00 ET | Truveta
BELLEVUE, Wash., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Today, Truveta, a growing collective of 30 health systems with a shared mission of Saving Lives with Data, was awarded a contract with the U.S....
Truveta Research found that patients with overweight or obesity taking tirzepatide (Mounjaro) experienced a greater percentage change in body weight than those taking semaglutide (Ozempic) for weight loss.
Largest real-world study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
November 27, 2023 09:00 ET | Truveta
BELLEVUE, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Today Truveta announced new comparative effectiveness research exploring weight loss among patients taking semaglutide (Ozempic) and tirzepatide...
Axtria and HealthVerity Announce Strategic Partnership
Axtria and HealthVerity Announce Strategic Partnership to Enable Next-Gen Real-World Data, Analytics, and Campaign Optimization Solutions for Life Sciences Organizations
April 13, 2023 08:00 ET | Axtria Inc.
Berkeley Heights, NJ and Philadelphia, PA, April 13, 2023 (GLOBE NEWSWIRE) -- Axtria, Inc., a global leader of award-winning cloud software and data analytics, and HealthVerity, the leader in...